Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 1,266,903 INDV shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Indivior Pharmaceuticals, Inc. (INDV) | Exercise/Conversion | 1,266,903 | n/a |
| Feb 12, 2026 | Indivior Pharmaceuticals, Inc. (INDV) | Grant/Award | 79,976 | n/a |
| Feb 14, 2024 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 119,000 | n/a |
| Dec 22, 2023 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Exercise/Conversion | 4,357 | $93.0K |
| Dec 20, 2023 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Exercise/Conversion | 27,798 | $593.2K |
| Jun 2, 2023 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Sale | 31,272 | $690.8K |
| Jun 1, 2023 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Sale | 31,271 | $684.9K |
| Feb 14, 2023 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 117,500 | n/a |
| Dec 28, 2022 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Sale | 110 | $2.5K |
| Dec 22, 2022 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Sale | 1,134 | $26.1K |